About the Company
IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases.
Employees
57
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ISEE News
Astellas to Buy Eye-Drug Maker Iveric Bio for $5.9 Billion
(Bloomberg) -- Japanese drugmaker Astellas Pharma Inc. agreed to acquire Iveric Bio Inc., a developer of drugs to treat age-related blindness, for about $5.9 billion. The deal, which will be ...
First Republic sinks after JPMorgan takeover, while Norwegian Cruise, Lordstown Motors and SoFi shares are also on the move
Shares of Iveric Bio Inc. jumped 14% after Japan’s Astellas Pharma Inc. said it would acquire the biopharmaceutical company for about $5.9 billion, or $40 per share in cash, a nearly 22% premium ...
Versant Venture Capital IV, L.P.'s Net Worth
Who is Versant Venture Capital IV, L.P.? Versant Venture Capital IV, L.P. has an estimated net worth of $7.76 Million. This is based on reported shares across multiple companies, which include ...
EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer
Company on-track to report topline data in 2Q 2024 for the Phase 2 PAVIA clinical trial of EYP-1901 in moderately severe-to-severe NPDR –– ...
bluebird bio, Inc. (BLUE)
SOMERVILLE, Mass., March 11, 2024--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio") today announced it has signed its first Medicaid outcomes-based agreement for LYFGENIA™ (lovotibeglogene ...
Versant Side Fund IV, L.P.'s Net Worth
Who is Versant Side Fund IV, L.P.? Versant Side Fund IV, L.P. has an estimated net worth of $7.71 Million. This is based on reported shares across multiple companies, which include Oyster Point ...
TRML Tourmaline Bio, Inc.
Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases. It develops TOUR006, a human anti-IL-6 monoclonal ...
Gossamer Bio Inc GOSS
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
NUUU Rejuvel Bio-Sciences, Inc.
Rejuvel Bio-Sciences, Inc., a development stage company, produces, distributes, markets, and sells skin care products worldwide. The company primarily offers skin cream under the Rejuvel brand.
Palisade Bio, Inc.
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post ...
bluebird bio, Inc.
bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Loading the latest forecasts...